GLP-1 and glucose tolerance after sleeve gastrectomy in morbidly obese subjects with type 2 diabetes. 2014

Amanda Jiménez, and Andrea Mari, and Roser Casamitjana, and Antonio Lacy, and Ele Ferrannini, and Josep Vidal
Obesity Unit, Hospital Clinic Universitari, Barcelona, Spain Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

Although GLP-1 has been suggested as a major factor for the marked improvement of glucose tolerance commonly seen after sleeve gastrectomy (SG), several observations challenge this hypothesis. To better understand the role of GLP-1 in the remission of type 2 diabetes mellitus (T2DM) long term after SG in humans, we conducted two separate cross-sectional studies: 1) the GLP-1 response to a standardized mixed liquid meal (SMLM) was compared in subjects with T2DM antedating SG but with different long-term (>2 years) T2DM outcomes (remission, relapse, or lack of remission) (study 1) and 2) the effect of GLP-1 receptor blockade with exendin (9-39) on glucose tolerance was examined in subjects with T2DM antedating surgery, who had undergone SG and presented with long-term T2DM remission (study 2). In study 1, we observed a comparable GLP-1 response to the SMLM regardless of the post-SG outcome of T2DM. In study 2, the blockade of GLP-1 action resulted in impaired insulin secretion but limited deterioration of glucose tolerance. Thus, our data suggest the enhanced GLP-1 secretion observed long term after SG is neither sufficient nor critical to maintain normal glucose tolerance in subjects with T2DM antedating the surgery.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009767 Obesity, Morbid The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2. Morbid Obesity,Obesity, Severe,Morbid Obesities,Obesities, Morbid,Obesities, Severe,Severe Obesities,Severe Obesity
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D005743 Gastrectomy Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed) Gastrectomies
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Amanda Jiménez, and Andrea Mari, and Roser Casamitjana, and Antonio Lacy, and Ele Ferrannini, and Josep Vidal
March 2010, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery,
Amanda Jiménez, and Andrea Mari, and Roser Casamitjana, and Antonio Lacy, and Ele Ferrannini, and Josep Vidal
January 2013, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery,
Amanda Jiménez, and Andrea Mari, and Roser Casamitjana, and Antonio Lacy, and Ele Ferrannini, and Josep Vidal
December 2006, Obesity surgery,
Amanda Jiménez, and Andrea Mari, and Roser Casamitjana, and Antonio Lacy, and Ele Ferrannini, and Josep Vidal
May 2009, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery,
Amanda Jiménez, and Andrea Mari, and Roser Casamitjana, and Antonio Lacy, and Ele Ferrannini, and Josep Vidal
May 2019, Journal of laparoendoscopic & advanced surgical techniques. Part A,
Amanda Jiménez, and Andrea Mari, and Roser Casamitjana, and Antonio Lacy, and Ele Ferrannini, and Josep Vidal
July 2013, Diabetes care,
Amanda Jiménez, and Andrea Mari, and Roser Casamitjana, and Antonio Lacy, and Ele Ferrannini, and Josep Vidal
January 2011, Journal of obesity,
Amanda Jiménez, and Andrea Mari, and Roser Casamitjana, and Antonio Lacy, and Ele Ferrannini, and Josep Vidal
January 2016, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery,
Amanda Jiménez, and Andrea Mari, and Roser Casamitjana, and Antonio Lacy, and Ele Ferrannini, and Josep Vidal
May 2014, Clinical endocrinology,
Amanda Jiménez, and Andrea Mari, and Roser Casamitjana, and Antonio Lacy, and Ele Ferrannini, and Josep Vidal
March 2019, Internal medicine (Tokyo, Japan),
Copied contents to your clipboard!